SYRE stock results show that Spyre Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. More
Articles
HGBL Stock Earnings: Heritage Glb Misses EPS, Misses Revenue for Q1 2024
HGBL stock results show that Heritage Glb missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. More
GYRE Stock Earnings: Gyre Therapeutics Reported Results for Q1 2024
Gyre Therapeutics just reported results for the first quarter of 2024. More
COYA Stock Earnings: Coya Therapeutics Misses EPS for Q1 2024
COYA stock results show that Coya Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. More
CNNE Stock Earnings: Cannae Holdings Misses EPS, Misses Revenue for Q1 2024
CNNE stock results show that Cannae Holdings missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. More
SCM Stock Earnings: Stellus Cap Investment Misses EPS, Misses Revenue for Q1 2024
SCM stock results show that Stellus Cap Investment missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. More
ATXS Stock Earnings: Astria Therapeutics Misses EPS for Q1 2024
ATXS stock results show that Astria Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. More
